Jerry Shapiro

12.6k total citations · 3 hit papers
201 papers, 7.2k citations indexed

About

Jerry Shapiro is a scholar working on Urology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Jerry Shapiro has authored 201 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Urology, 106 papers in Dermatology and 29 papers in Pathology and Forensic Medicine. Recurrent topics in Jerry Shapiro's work include Hair Growth and Disorders (173 papers), Dermatologic Treatments and Research (53 papers) and Autoimmune Bullous Skin Diseases (28 papers). Jerry Shapiro is often cited by papers focused on Hair Growth and Disorders (173 papers), Dermatologic Treatments and Research (53 papers) and Autoimmune Bullous Skin Diseases (28 papers). Jerry Shapiro collaborates with scholars based in United States, Canada and Australia. Jerry Shapiro's co-authors include Kevin J. McElwee, Shabnam Madani, Kristen Lo Sicco, Eddy Wang, Adel Alsantali, Abdullah Alkhalifah, Nina Otberg, Lauren C. Strazzulla, Lorena Avila and Eileen Tan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Jerry Shapiro

194 papers receiving 6.9k citations

Hit Papers

Alopecia areata update 2010 2026 2015 2020 2010 2017 2023 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Alopecia areata update
    2010 451 citations Jerry Shapiro et al. Journal of the American Academy of Dermatology profile →
  2. Alopecia areata
    2017 346 citations Kristen Lo Sicco, Jerry Shapiro et al. Journal of the American Academy of Dermatology profile →
  3. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
    2023 134 citations Brett King, Xingqi Zhang et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jerry Shapiro 5.2k 3.9k 1.2k 1.1k 818 201 7.2k
Andrew G. Messenger 5.2k 1.0× 3.8k 1.0× 2.2k 1.8× 663 0.6× 1.1k 1.4× 148 7.3k
Maria Hordinsky 3.1k 0.6× 2.5k 0.6× 1.2k 1.0× 656 0.6× 677 0.8× 135 4.9k
Elise A. Olsen 4.1k 0.8× 6.9k 1.8× 1.2k 1.0× 2.9k 2.6× 1.4k 1.8× 132 10.5k
Amos Gilhar 2.1k 0.4× 1.9k 0.5× 989 0.8× 470 0.4× 862 1.1× 134 4.7k
Ralph M. Trüeb 1.6k 0.3× 1.3k 0.3× 528 0.5× 551 0.5× 303 0.4× 144 3.0k
Salvador Arias‐Santiago 896 0.2× 2.1k 0.5× 354 0.3× 648 0.6× 632 0.8× 322 5.3k
Amy McMichael 1.5k 0.3× 2.1k 0.5× 676 0.6× 383 0.3× 236 0.3× 156 3.1k
Natasha Atanaskova Mesinkovska 1.3k 0.2× 1.5k 0.4× 292 0.2× 323 0.3× 288 0.4× 212 2.8k
John Harper 260 0.0× 2.8k 0.7× 1.1k 0.9× 902 0.8× 1.0k 1.2× 120 5.8k
Alberto Giannetti 240 0.0× 2.5k 0.6× 735 0.6× 754 0.7× 1.1k 1.4× 163 6.3k

Countries citing papers authored by Jerry Shapiro

Since Specialization
Citations

This map shows the geographic impact of Jerry Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Shapiro more than expected).

Fields of papers citing papers by Jerry Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Shapiro. The network helps show where Jerry Shapiro may publish in the future.

Co-authorship network of co-authors of Jerry Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry Shapiro. A scholar is included among the top collaborators of Jerry Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry Shapiro. Jerry Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
­Jimenez‐Cauhe, Juan, Kristen I. Lo Sicco, Jerry Shapiro, et al.. (2025). Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review. Journal of Clinical Medicine. 14(6). 1805–1805. 4 indexed citations
2.
Avram, Marc R., et al.. (2025). Improvement in Scalp Hair Appearance Following Treatment With a Non‐Ablative Fractional Laser: A Retrospective Observational Study. Lasers in Surgery and Medicine. 57(7). 590–597. 1 indexed citations
3.
Markova, Alina, Azael Freites‐Martínez, Ian Tattersall, et al.. (2025). Low-Dose Oral Minoxidil during Chemotherapy: A Review of the Mechanism and Current Evidence. Skin Appendage Disorders. 12(1). 29–37.
4.
Mostaghimi, Arash, Brittany G. Craiglow, Brett King, et al.. (2025). Understanding eyebrow and eyelash involvement in patients with alopecia areata and responsiveness to treatment with baricitinib. British Journal of Dermatology. 193(2). 240–249. 1 indexed citations
5.
Lee, Alison, et al.. (2024). Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata. Journal of the American Academy of Dermatology. 91(5). 976–978.
6.
King, Brett, Manabu Ohyama, Maryanne M. Senna, et al.. (2024). Outcomes of down-titration in patients with severe scalp alopecia areata initially treated with baricitinib 4-mg: Week 152 data from BRAVE-AA2. Journal of the American Academy of Dermatology. 92(2). 299–306. 4 indexed citations
7.
8.
9.
10.
Shapiro, Jerry, et al.. (2023). Commonly used hair oils in the Black community: a narrative review in their use to treat androgenetic alopecia. International Journal of Dermatology. 62(8). 980–985. 3 indexed citations
11.
Shapiro, Jerry, Justin Ko, Alexander Egeberg, et al.. (2023). 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata. Journal of the American Academy of Dermatology. 89(3). AB127–AB127. 1 indexed citations
12.
Klein, Elizabeth J., et al.. (2023). A practical approach to the management of hair loss in patients with polycystic ovary syndrome. Journal of the European Academy of Dermatology and Venereology. 37(8). 1480–1489. 2 indexed citations
13.
Shapiro, Jerry, et al.. (2023). Platelet-Rich Plasma Applications, The Past 5 Years: A Review Article. SHILAP Revista de lepidopterología. 3 indexed citations
14.
King, Brett, Jerry Shapiro, Manabu Ohyama, et al.. (2023). When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials. British Journal of Dermatology. 189(6). 666–673. 25 indexed citations
15.
King, Brett, Xingqi Zhang, Jacek C. Szepietowski, et al.. (2023). A Plain Language Summary on Ritlecitinib Treatment for Adults and Adolescents with Alopecia Areata. Immunotherapy. 15(14). 1093–1103. 4 indexed citations
16.
King, Brett, Manabu Ohyama, Maryanne M. Senna, et al.. (2023). 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2. Journal of the American Academy of Dermatology. 89(3). AB69–AB69. 1 indexed citations
17.
Senna, Maryanne M., Justin Ko, Susan Ball, et al.. (2022). Predictors of QOL in Patients with Alopecia Areata. Journal of Investigative Dermatology. 142(10). 2646–2650.e3. 25 indexed citations
18.
Ramos, Paulo Müller, John McCoy, Carlos Gustavo Wambier, et al.. (2020). Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response. Journal of the European Academy of Dermatology and Venereology. 34(12). e799–e800. 5 indexed citations
19.
McCoy, John, Flavio Cadegiani, Carlos Gustavo Wambier, et al.. (2020). 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia. Journal of the European Academy of Dermatology and Venereology. 35(4). e243–e246. 27 indexed citations
20.
Goren, Andy, Jerry Shapiro, Janet L. Roberts, et al.. (2014). Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatologic Therapy. 28(1). 13–16. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew G. Messenger Breakdown of academic impact, for papers by Maria Hordinsky Breakdown of academic impact, for papers by Elise A. Olsen Breakdown of academic impact, for papers by Amos Gilhar Breakdown of academic impact, for papers by Ralph M. Trüeb Breakdown of academic impact, for papers by Salvador Arias‐Santiago Breakdown of academic impact, for papers by Amy McMichael Breakdown of academic impact, for papers by Natasha Atanaskova Mesinkovska Breakdown of academic impact, for papers by John Harper Breakdown of academic impact, for papers by Alberto Giannetti
Rankless by CCL
2026